FINANCIAL NEWS FAST

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

A Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.A Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.Read More

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on linkedin
LinkedIn
On Key

Related Posts

Fortune Org is an international news provider focusing on trusted financial, political, and world news for professionals and organizations. Our editor in chief Brian Edwards runs our tight-knit team of investigative journalists and finance researchers from the UK and Australia that contribute to curated news content, op-eds, and investigative pieces.

Financial News Fast

Copyright © 2020 Fortune Org.